Prothena Corporation plc
PRTA
$7.59
-$0.02-0.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5,556.00% | 571.84% | -98.86% | 3,184.75% | -97.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5,556.00% | 571.84% | -98.86% | 3,184.75% | -97.69% |
| Cost of Revenue | -20.75% | -18.93% | -12.42% | 2.68% | 43.25% |
| Gross Profit | 25.10% | 21.97% | -284.59% | 243.30% | -50.43% |
| SG&A Expenses | 0.77% | -0.54% | 0.69% | 11.13% | 27.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.14% | -14.98% | -9.49% | 4.42% | 39.46% |
| Operating Income | 19.56% | 17.34% | -745.26% | 187.78% | -44.75% |
| Income Before Tax | 17.55% | 15.74% | -418.02% | 210.09% | -49.55% |
| Income Tax Expenses | 46.48% | 50.83% | 72.99% | 52.65% | 24.42% |
| Earnings from Continuing Operations | 16.67% | 14.11% | -369.32% | 222.51% | -54.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.67% | 14.11% | -369.32% | 222.51% | -54.15% |
| EBIT | 19.56% | 17.34% | -745.26% | 187.78% | -44.75% |
| EBITDA | 19.62% | 17.34% | -729.09% | 188.42% | -44.88% |
| EPS Basic | 16.85% | 14.35% | -368.19% | 221.05% | -50.67% |
| Normalized Basic EPS | 17.73% | 15.98% | -416.62% | 208.77% | -46.17% |
| EPS Diluted | 16.85% | 14.35% | -389.47% | 218.45% | -50.67% |
| Normalized Diluted EPS | 17.73% | 15.98% | -443.02% | 206.25% | -46.17% |
| Average Basic Shares Outstanding | 0.21% | 0.27% | 0.43% | 1.22% | 2.31% |
| Average Diluted Shares Outstanding | 0.21% | 0.27% | -7.27% | 3.62% | 2.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |